staurosporine has been researched along with acetazolamide in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 7 (70.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Abdel-Aziz, HA; Abou-Seri, SM; Bonardi, A; Eldehna, WM; Elgazar, AA; Fahim, SH; Gratteri, P; Kryštof, V; Nocentini, A; Said, MA; Soliman, DH; Supuran, CT | 1 |
| Abdel-Aziz, HA; Abdel-Maksoud, MS; Abo-Ashour, MF; Al-Sanea, MM; Al-Warhi, T; Alkhaldi, AAM; Bonardi, A; El-Damasy, AK; El-Haggar, R; Eldehna, WM; Elsayed, ZM; Gratteri, P; Nocentini, A; Supuran, CT | 1 |
| Beteck, RM; Jesumoroti, OJ; Legoabe, LJ; Patel, OPS | 1 |
| Abdel-Aziz, HA; Capasso, C; El-Domany, RA; Eldehna, WM; Elsayed, ZM; Ibrahim, TM; Nocentini, A; Salem, R; Shaldam, M; Supuran, CT | 1 |
| Abdel-Aziz, HA; Abdelfadil, M; Badria, FA; Bonardi, A; El-Domany, RA; Eldehna, WM; Elgazar, AA; Elimam, DM; Nocentini, A; Supuran, CT | 1 |
| Al-Rashood, ST; Allam, HA; Bonardi, A; Elaasser, MM; Eldehna, WM; Elimam, DM; Gratteri, P; Nocentini, A; Salem, R; Supuran, CT | 1 |
| El-Hamamsy, MH; Petreni, A; Supuran, CT; Tawfik, HO | 1 |
1 review(s) available for staurosporine and acetazolamide
| Article | Year |
|---|---|
Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antiprotozoal Agents; Drug Development; Humans; Hypoglycemic Agents; Metronidazole | 2021 |
9 other study(ies) available for staurosporine and acetazolamide
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation.
Topics: Antineoplastic Agents; Azo Compounds; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Humans; In Vitro Techniques; Molecular Docking Simulation; Molecular Structure; Neoplasms; Pyrazoles; Structure-Activity Relationship; Sulfonamides | 2020 |
3-Methylthiazolo[3,2-a]benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and molecular modeling studies.
Topics: Antineoplastic Agents; Apoptosis; Benzenesulfonamides; Benzimidazoles; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Catalytic Domain; Cell Cycle; Cell Proliferation; Drug Design; Humans; Isoenzymes; MCF-7 Cells; Models, Molecular; Sulfonamides | 2020 |
Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors.
Topics: Antigens, Neoplasm; Benzofurans; Binding Sites; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Cell Line, Tumor; Cell Survival; Drug Evaluation, Preclinical; Humans; Isoenzymes; Molecular Docking Simulation; Phenylurea Compounds; Structure-Activity Relationship; Sulfonamides | 2021 |
Natural inspired piperine-based sulfonamides and carboxylic acids as carbonic anhydrase inhibitors: Design, synthesis and biological evaluation.
Topics: Antineoplastic Agents; Biological Products; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Carboxylic Acids; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Humans; MCF-7 Cells; Molecular Structure; Structure-Activity Relationship; Sulfonamides | 2021 |
Natural inspired ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors.
Topics: Antineoplastic Agents, Phytogenic; Biological Products; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Isoenzymes; MCF-7 Cells; Models, Molecular; Molecular Structure; Phenylurea Compounds; Pyrazines; Structure-Activity Relationship; Sulfonamides | 2022 |
Discovery of new carbonic anhydrase IX inhibitors as anticancer agents by toning the hydrophobic and hydrophilic rims of the active site to encounter the dual-tail approach.
Topics: Antineoplastic Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carcinoma, Hepatocellular; Catalytic Domain; Humans; Liver Neoplasms; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2022 |